|
Originally published In Press as doi:10.1074/jbc.M603395200 on May 16, 2006
J. Biol. Chem., Vol. 281, Issue 29, 20027-20035, July 21, 2006
Genetic Basis for the Synthesis of the Immunomodulatory Mannose Caps of Lipoarabinomannan in Mycobacterium tuberculosis*
Premkumar Dinadayala,
Devinder Kaur,
Stefan Berg,
Anita G. Amin,
Varalakshmi D. Vissa,
Delphi Chatterjee,
Patrick J. Brennan, and
Dean C. Crick1
From the
Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado 80523-1682
Lipoarabinomannan (LAM) is a high molecular weight, heterogenous lipoglycan present in abundant quantities in Mycobacterium tuberculosis and many other actinomycetes. In M. tuberculosis, the non-reducing arabinan termini of the LAM are capped with 1 2 mannose residues; in some other species, the arabinan of LAM is not capped or is capped with inositol phosphate. The nature and extent of this capping plays an important role in disease pathogenesis. MT1671 in M. tuberculosis CDC1551 was identified as a glycosyltransferase that could be involved in LAM capping. To determine the function of this protein a mutant strain of M. tuberculosis CDC1551 was studied, in which MT1671 was disrupted by transposition. SDS-PAGE analysis showed that the LAM of the mutant strain migrated more rapidly than that of the wild type and did not react with concanavalin A as did wild-type LAM. Structural analysis using NMR, gas chromatography/mass spectrometry, endoarabinanase digestion, Dionex high pH anion exchange chromatography, and matrix-assisted laser desorption ionization-time-of-flight mass spectrometry demonstrated that the LAM of the mutant strain was devoid of mannose capping. Since an ortholog of MT1671 is not present in Mycobacterium smegmatis mc2155, a recombinant strain was constructed that expressed this protein. Analysis revealed that the LAM of the recombinant strain was larger than that of the wild type, had gained concanavalin A reactivity, and that the arabinan termini were capped with a single mannose residue. Thus, MT1671 is the mannosyltransferase involved in deposition of the first of the mannose residues on the non-reducing arabinan termini and the basis of much of the interaction between the tubercle bacillus and the host cell.
Received for publication, April 10, 2006
, and in revised form, May 16, 2006.
* This work was supported by National Institutes of Health/NIAID Grants AI49151 (to D. C. C.), AI64798 and AI18357 (to P. J. B.), and AI37139 (to D. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 To whom correspondence should be addressed. Tel.: 970-491-3308; Fax: 970-491-1815; E-mail: dean.crick{at}colostate.edu.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. B Torrelles, L. E DesJardin, J. MacNeil, T. M Kaufman, B. Kutzbach, R. Knaup, T. R McCarthy, S. S Gurcha, G. S Besra, S. Clegg, et al.
Inactivation of Mycobacterium tuberculosis mannosyltransferase pimB reduces the cell wall lipoarabinomannan and lipomannan content and increases the rate of bacterial-induced human macrophage cell death
Glycobiology,
July 1, 2009;
19(7):
743 - 755.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Kaur, A. Obregon-Henao, H. Pham, D. Chatterjee, P. J. Brennan, and M. Jackson
Lipoarabinomannan of Mycobacterium: Mannose capping by a multifunctional terminal mannosyltransferase
PNAS,
November 18, 2008;
105(46):
17973 - 17977.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Kaur, M. R. McNeil, K.-H. Khoo, D. Chatterjee, D. C. Crick, M. Jackson, and P. J. Brennan
New Insights into the Biosynthesis of Mycobacterial Lipomannan Arising from Deletion of a Conserved Gene
J. Biol. Chem.,
September 14, 2007;
282(37):
27133 - 27140.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. V. V. Tatituri, L. J. Alderwick, A. K. Mishra, J. Nigou, M. Gilleron, K. Krumbach, P. Hitchen, A. Giordano, H. R. Morris, A. Dell, et al.
Structural characterization of a partially arabinosylated lipoarabinomannan variant isolated from a Corynebacterium glutamicum ubiA mutant
Microbiology,
August 1, 2007;
153(8):
2621 - 2629.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Berg, D. Kaur, M. Jackson, and P. J Brennan
The glycosyltransferases of Mycobacterium tuberculosis--roles in the synthesis of arabinogalactan, lipoarabinomannan, and other glycoconjugates
Glycobiology,
June 1, 2007;
17(6):
35R - 56R.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. V. V. Tatituri, P. A. Illarionov, L. G. Dover, J. Nigou, M. Gilleron, P. Hitchen, K. Krumbach, H. R. Morris, N. Spencer, A. Dell, et al.
Inactivation of Corynebacterium glutamicum NCgl0452 and the Role of MgtA in the Biosynthesis of a Novel Mannosylated Glycolipid Involved in Lipomannan Biosynthesis
J. Biol. Chem.,
February 16, 2007;
282(7):
4561 - 4572.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. S. Morita, C. B. C. Sena, R. F. Waller, K. Kurokawa, M. F. Sernee, F. Nakatani, R. E. Haites, H. Billman-Jacobe, M. J. McConville, Y. Maeda, et al.
PimE Is a Polyprenol-phosphate-mannose-dependent Mannosyltransferase That Transfers the Fifth Mannose of Phosphatidylinositol Mannoside in Mycobacteria
J. Biol. Chem.,
September 1, 2006;
281(35):
25143 - 25155.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|